Original news and analysis on international IP policy
Will an international instrument protecting genetic resources get in the way of the world’s preparedness to fend off the next influenza pandemic? This is one of the questions left open for a group of experts reviewing the World Health Organization Pandemic Influenza Preparedness (PIP) Framework. Meanwhile, one stakeholder is claiming to have been denied full and fair participation.
The global treatment of influenza is under reconsideration at the World Health Organization this week, as a review group of a WHO influenza pandemic framework looks at issues such as its relationship with an international treaty protecting countries’ ownership biological resources.
A World Health Organization framework to respond to influenza pandemics is working successfully, the confidential draft report of a review team has found. But some areas, such as virus genetic information, still need more work. Stakeholders, meanwhile, are challenging some findings and a concern was raised that lawyers may be influencing the science behind decisions on this issue.
When a deadly influenza virus appears and threatens to become a pandemic, time is of the essence. The 1918 flu epidemic infected a large portion of the global population and killed millions of people. The next pandemic is inevitable, and surveillance of flu viruses is essential through the timely sharing of flu virus genetic data with the scientific and research communities. A collaborative database has become prominent in recent years.
The review of a World Health Organization mechanism for sharing pandemic influenza viruses while ensuring access to vaccines for developing countries is nearing conclusion. Next week, the reviewers will hold their last meeting, including an open session for governments and stakeholders to share views. The review is addressing issues such as the mechanism’s relationship with other international rules, and how to handle the rising use of genetic data instead of biological samples.
Antimicrobial resistance has been described as a major threat to public health, as infections, even minor, might become killers again, if no new antibiotics are discovered. In October, the World Health Organization, World Intellectual Property Organization and World Trade Organization will join forces for a symposium organised to discuss how to foster innovation, and access.
There are many, many committees, councils, panels, meetings, receptions, conferences, assemblies - not to mention countless private lunches, coffees and other contacts - during the year in Geneva that address policy issues related to intellectual property, innovation, research & development and the like. Intellectual Property Watch provides an indispensable, up-to-date list of who you need to talk to when you want to get the message across or follow the action.
Over the summer months, people in the intellectual property world continue to circulate. UNITAID has changed heads, and other well-known figures in Geneva set off to new horizons. And no rest it seems for law offices, which maintained their usual level of moves between firms. Here is the latest on People in the IP community.
Details of the upcoming United Nations General Assembly High-Level Meeting on Antimicrobial Resistance (AMR) are coming clear after the preparation of a text laying out the specifics.
DURBAN, South Africa - The international medical humanitarian organisation Médecins Sans Frontières (MSF) has found that prices of older HIV drugs continue to decline, but newer drugs largely remain expensive.